AMGN - U.S. govt. sends opening bids for drugs selected for Medicare pricing negotiations
2024-02-01 10:13:39 ET
More on Bristol-Myers Squibb, Johnson & Johnson, etc.
- Pfizer Is Down 54% From Highs, Now Yields 6.1%
- Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value
- Pfizer: Reviewing Q4 Earnings, FY24 Guidance - Why I Disagree With The Market
- Lilly, Novo could be first trillion-dollar health stocks: world's largest sovereign wealth fund
- J&J seeks expanded FDA approval of Darzalex Faspro for multiple myeloma